Intravesical Electromotive Botulinum Toxin Type A (Dysport ®) Administration in Children with Myelomeningocele
Electromotive drug administration (EMDA) presents a minimally-invasive method of intravesical instillation of therapeutic agents without the need for general anesthesia 1. It employs a combination of iontophoresis, electrophoresis, and electroporation to deliver drugs into deep tissue layers using an electrical current created between two electrodes 2. This video shows feasibility of botulinum toxin type A (BoNTA) EMDA in myelomeningocele (MMC) children with urinary incontinence secondary to neuropathic detrusor overactivity.
Source: Urology - Category: Urology & Nephrology Authors: Lida Sharifi-Rad, Seyedeh-Sanam Ladi-Seyedian, Behnam Nabavizadeh, Maryam Alijani, Abdol-Mohammad Kajbafzadeh Tags: Video Article Source Type: research
More News: Abobotulinumtoxin A | Anesthesia | Anesthesiology | Botox | Brain | Children | Incontinence | Neurology | Urology & Nephrology